Jul 6, 2026 08:45AM
Jun 29, 2026 09:30AM
Jun 29, 2026 09:30AM
Jun 25, 2026 09:20AM
Jun 25, 2026 09:20AM
Jun 22, 2026 09:00AM
Jun 11, 2026 09:02AM NeuroSense receives South Korean patent for ALS drug PrimeC
Jun 11, 2026 09:00AM
Jun 9, 2026 09:01AM
Jun 9, 2026 09:00AM
Apr 6, 2026 09:20AM
Apr 6, 2026 09:20AM
Mar 31, 2026 09:20AM
Mar 24, 2026 09:03AM NeuroSense reschedules Health Canada meeting to include additional data
Mar 24, 2026 09:00AM
Mar 18, 2026 08:00AM
Mar 16, 2026 11:34AM
Mar 16, 2026 11:33AM
Mar 9, 2026 11:07AM
Feb 18, 2026 09:05AM
Feb 18, 2026 09:05AM NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS
Feb 9, 2026 09:20AM
Feb 9, 2026 09:20AM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Jan 8, 2026 08:45AM
Dec 22, 2025 09:18AM
Dec 22, 2025 09:17AM NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer's Phase 2 Study
Dec 4, 2025 07:30AM
Nov 24, 2025 09:56AM
Nov 24, 2025 09:56AM
Oct 6, 2025 09:00AM
Sep 10, 2025 02:30PM
Sep 4, 2025 08:49AM
Sep 4, 2025 08:49AM NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
Aug 1, 2025 09:00AM
Jul 22, 2025 08:42AM
Apr 24, 2025 09:09AM
Apr 24, 2025 09:09AM
Apr 9, 2025 08:30AM
Apr 9, 2025 08:30AM
Apr 7, 2025 05:14PM NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates
Apr 4, 2025 09:10AM
Mar 20, 2025 10:30AM
Mar 17, 2025 08:30AM
Jan 6, 2025 09:02AM
Jan 6, 2025 09:00AM
Dec 23, 2024 09:00AM
Dec 18, 2024 10:25AM NeuroSense Provides Business Update and Third Quarter 2024 Financial Results
Dec 11, 2024 09:25AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All